Although RARAα fusion proteins are required for APL leukemogenesis, additional genetic aberrations such as mutations in FLT3, which encodes FMS-like tyrosine kinase 3, are frequently found in APL and might contribute to its pathogenesis and outcome [3]. This evidence concerns the gene FLT3 and acute promyelocytic leukemia.